PRTG Cash Flow Statement - Portage Biotech Inc - Alpha Spread

Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 10.21 USD 3.03% Market Closed
Market Cap: 214.4m USD
Have any thoughts about
Portage Biotech Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
Portage Biotech Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Operating Cash Flow
Net Income
(4)
(4)
(5)
(4)
(4)
(5)
(9)
(9)
(13)
22
21
(1)
4
(30)
(24)
124
124
124
124
(4)
(5)
(7)
(8)
(7)
(6)
(7)
(7)
(17)
(20)
(20)
(23)
(19)
(18)
(16)
(19)
(105)
(109)
(113)
(145)
(75)
(71)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Deffered Taxes
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
3
2
2
4
2
(0)
2
(18)
(15)
(14)
(26)
(11)
0
Other Non-Cash Items
1
1
1
1
1
1
4
4
5
(29)
(27)
(1)
(2)
32
27
(125)
(125)
(125)
(125)
2
3
3
4
4
3
4
4
11
13
14
15
8
8
7
7
110
111
111
155
71
68
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
(0)
0
1
1
0
(1)
(1)
(1)
0
0
0
(0)
(1)
0
(0)
0
(0)
(0)
0
1
1
1
1
(0)
(0)
(1)
(1)
(1)
(1)
(0)
0
(0)
1
0
1
(0)
(0)
1
(0)
1
1
Cash from Operating Activities
(3)
N/A
(3)
-2%
(3)
-8%
(3)
+6%
(3)
-20%
(5)
-49%
(6)
-20%
(6)
-4%
(8)
-38%
(7)
+15%
(6)
+17%
(1)
+77%
2
N/A
2
+55%
2
-6%
(1)
N/A
(1)
+6%
(1)
+7%
(1)
+27%
(1)
-25%
(2)
-92%
(3)
-64%
(3)
-20%
(4)
-14%
(3)
+8%
(4)
-19%
(4)
-4%
(4)
-2%
(5)
-21%
(5)
+12%
(5)
-19%
(7)
-25%
(7)
-9%
(9)
-17%
(10)
-12%
(12)
-25%
(13)
-11%
(15)
-13%
(16)
-5%
(14)
+10%
(13)
+12%
Investing Cash Flow
Capital Expenditures
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Items
0
0
0
0
0
(2)
(2)
(2)
(3)
0
0
(3)
(2)
0
0
6
0
0
5
(0)
0
0
1
0
(1)
(1)
(1)
(1)
0
0
0
0
0
(1)
(1)
(1)
0
0
0
3
0
Cash from Investing Activities
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
(2)
N/A
(2)
N/A
(2)
N/A
(3)
-59%
0
N/A
0
N/A
(3)
N/A
(2)
+29%
0
N/A
0
N/A
6
N/A
0
N/A
0
N/A
5
N/A
(0)
N/A
0
N/A
0
N/A
1
N/A
0
N/A
(1)
N/A
(1)
+14%
(1)
N/A
(1)
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
(1)
N/A
(1)
N/A
(1)
N/A
0
N/A
0
N/A
0
N/A
3
N/A
0
N/A
Financing Cash Flow
Net Issuance of Common Stock
0
1
2
2
7
7
5
6
1
1
1
0
0
0
1
3
2
2
2
0
0
0
0
0
7
7
7
7
29
29
29
29
0
0
1
3
4
4
3
1
0
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
0
(0)
(0)
(0)
0
(1)
(1)
(1)
0
0
0
0
0
(2)
(2)
(2)
(2)
(0)
(0)
(0)
(0)
Other
0
0
0
0
0
2
2
4
11
3
2
0
(7)
0
2
0
0
0
(2)
0
0
0
0
1
1
(0)
(0)
(1)
(3)
(2)
(2)
(2)
(0)
(1)
(1)
(1)
(1)
(0)
5
5
0
Cash from Financing Activities
0
N/A
1
+37%
2
+267%
2
-7%
7
+224%
9
+15%
8
-12%
11
+40%
12
+17%
4
-69%
3
-20%
0
-93%
(6)
N/A
1
N/A
3
+303%
3
-7%
2
-19%
2
-2%
(0)
N/A
(0)
N/A
0
N/A
(0)
N/A
(0)
-200%
1
N/A
7
+961%
6
-26%
6
+4%
5
-17%
25
+435%
27
+8%
27
N/A
27
0%
(0)
N/A
(3)
-3 663%
(2)
+26%
(0)
+95%
0
N/A
4
+621%
8
+129%
6
-26%
5
-10%
Change in Cash
Net Change in Cash
(2)
N/A
(2)
+7%
(0)
+82%
(0)
+9%
4
N/A
2
-49%
0
-90%
3
+1 250%
1
-50%
(3)
N/A
(3)
+13%
(5)
-68%
(7)
-55%
(0)
+96%
2
N/A
7
+305%
7
-7%
7
+0%
4
-42%
(1)
N/A
(2)
-57%
(3)
-52%
(3)
+6%
(3)
+1%
3
N/A
1
-80%
1
+8%
(0)
N/A
20
N/A
23
+12%
22
-4%
21
-6%
(7)
N/A
(12)
-64%
(13)
-2%
(13)
-2%
(13)
-5%
(12)
+14%
(8)
+33%
(6)
+29%
(4)
+21%
Free Cash Flow
Free Cash Flow
(3)
N/A
(3)
-2%
(3)
-8%
(3)
+6%
(3)
-20%
(5)
-49%
(6)
-20%
(6)
-4%
(8)
-38%
(7)
+15%
(6)
+17%
(1)
+77%
2
N/A
2
+55%
2
-6%
(1)
N/A
(1)
+6%
(1)
+7%
(1)
+27%
(1)
-25%
(2)
-92%
(3)
-64%
(3)
-20%
(4)
-14%
(3)
+8%
(4)
-19%
(4)
-4%
(4)
-2%
(5)
-21%
(5)
+12%
(5)
-19%
(7)
-25%
(7)
-9%
(9)
-17%
(10)
-12%
(12)
-25%
(13)
-11%
(15)
-13%
(16)
-5%
(14)
+10%
(13)
+12%

See Also

Discover More